Glyburide Tablet — FDA Drug Shortage

To Be Discontinued — Sanofi-Aventis U.S. LLC

The FDA lists a drug shortage record for Glyburide Tablet (tablet) from Sanofi-Aventis U.S. LLC with status To Be Discontinued. The shortage was first posted on Aug 10, 2026.

Shortage details

Status
To Be Discontinued
Company
Sanofi-Aventis U.S. LLC
Package NDC
0093-9433-01
Dosage Form
Tablet
Presentation
Diabeta, Tablet, 2.5 mg (NDC 0093-9433-01)
Initial Posting
Aug 10, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.